Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis


Autoria(s): Blaser, Cornelia; Klein, Matthias; Grandgirard, Denis; Wittwer, Matthias; Peltola, Heikki; Weigand, Michael; Koedel, Uwe; Leib, Stephen L.
Data(s)

2010

Resumo

Bacterial meningitis in children causes high rates of mortality and morbidity. In a recent clinical trial, oral glycerol significantly reduced severe neurological sequelae in paediatric meningitis caused by Haemophilus influenzae type b, and a tendency towards a benefit of adjunctive glycerol was seen in pneumococcal meningitis.

Formato

application/pdf

Identificador

http://boris.unibe.ch/2685/1/1471-2334-10-84.pdf

Blaser, Cornelia; Klein, Matthias; Grandgirard, Denis; Wittwer, Matthias; Peltola, Heikki; Weigand, Michael; Koedel, Uwe; Leib, Stephen L. (2010). Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis. BMC infectious diseases, 10(84), p. 84. London: BioMed Central 10.1186/1471-2334-10-84 <http://dx.doi.org/10.1186/1471-2334-10-84>

doi:10.7892/boris.2685

info:doi:10.1186/1471-2334-10-84

info:pmid:20353584

urn:issn:1471-2334

Idioma(s)

eng

Publicador

BioMed Central

Relação

http://boris.unibe.ch/2685/

Direitos

info:eu-repo/semantics/openAccess

Fonte

Blaser, Cornelia; Klein, Matthias; Grandgirard, Denis; Wittwer, Matthias; Peltola, Heikki; Weigand, Michael; Koedel, Uwe; Leib, Stephen L. (2010). Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis. BMC infectious diseases, 10(84), p. 84. London: BioMed Central 10.1186/1471-2334-10-84 <http://dx.doi.org/10.1186/1471-2334-10-84>

Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

PeerReviewed